Axsome Therapeutics, Inc. (NASDAQ:AXSM) Receives $259.05 Consensus PT from Brokerages
Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Free Report) have received an average recommendation of “Moderate Buy” from the twenty-two analysts that are covering the company, Marketbeat reports. One analyst has rated the stock with a sell rating, twenty have given a buy rating and one has given a strong buy rating to the […]
22 Jul 05:58 · The Markets Daily